Inventor · disambiguated record
Jennifer Leah Gori
Also filed as: GORI JENNIFER · GORI JENNIFER L · Gori Jennifer Leah
6 granted patents·23 pending applications·12 citations·filing 2016–2024
73Inventor score
Top patents by PatentIndex Score
29 records- 0189US11390884B2Optimized CRISPR/cas9 systems and methods for gene editing in stem cellsEDITAS MEDICINE INC·Filed 2016·Granted Jul 19, 2022·7 cites·16 claims
- 0287US11058725B2CA2 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Granted Jul 13, 2021·5 cites·21 claims
- 0373US2025243474A1Genome editing compositions and methods for treatment of chronic granulomatous diseasePRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 0470US2024011007A1Genome editing compositions and methods for treatment of chronic granulomatous diseasePRIME MEDICINE INC·Filed 2023·Application pending·0 cites
- 0570US2024360471A1Crispr/cas-related methods and compositions for treating beta hemoglobinopathiesEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 0670US2025179488A1Systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2024·Application pending·0 cites
- 0768US2024376466A1Genome editing compositions and methods for treatment of fanconi anemiaPRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 0868US2024252543A1Crispr/cas-related methods and compositions for improving transplantationEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 0966US2024417706A1Systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2023·Application pending·0 cites
- 1066US2023018543A1Crispr/cas-mediated gene conversionEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 1164US2023126434A1Optimized crispr/cas9 systems and methods for gene editing in stem cellsEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 1261US2023002760A1Crispr/cas-related methods, compositions and componentsEDITAS MEDICINE INC·Filed 2022·Application pending·0 cites
- 1359US12031132B2Systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2020·Granted Jul 9, 2024·0 cites·26 claims
- 1459US11851690B2Systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2019·Granted Dec 26, 2023·0 cites·12 claims
- 1551US11963982B2CRISPR/RNA-guided nuclease systems and methodsEDITAS MEDICINE INC·Filed 2019·Granted Apr 23, 2024·0 cites·18 claims
- 1650US2016281111A1Crispr/cas-mediated gene conversionEDITAS MEDICINE INC·Filed 2016·Application pending·0 cites
- 1750US2022170011A1Compositions and methods for tunable regulation of cas nucleasesOBSIDIAN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1850US2020299661A1Cpf1-related methods and compositions for gene editingEDITAS MEDICINE INC·Filed 2020·Application pending·0 cites
- 1949US2022175781A1Cd40l compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2048US2021386788A1Er tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2148US2024191197A1Modified cells and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2020·Application pending·0 cites
- 2247US11911415B2CRISPR/Cas-related methods and compositions for improving transplantationEDITAS MEDICINE INC·Filed 2016·Granted Feb 27, 2024·0 cites·27 claims
- 2347US2022073951A1Systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2020·Application pending·0 cites
- 2446US2020255857A1Crispr/cas-related methods and compositions for treating beta hemoglobinopathiesEDITAS MEDICINE INC·Filed 2017·Application pending·0 cites
- 2545US2022403001A1Pde5 derived regulatory constructs and methods of use in immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2645US2023026259A1Ca2 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2743US2018112213A1Crispr/cas-related methods, compositions and componentsEDITAS MEDICINE INC·Filed 2016·Application pending·0 cites
- 2841US2020263206A1Targeted integration systems and methods for the treatment of hemoglobinopathiesEDITAS MEDICINE INC·Filed 2018·Application pending·0 cites
- 2936US2018119123A1Crispr/cas-related methods and compositions for treating hiv infection and aidsEDITAS MEDICINE INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jennifer Leah Gori files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →